the folks at Motley Fool estimated that current CAPE overstates S&P valuation by 38% when outlier data is removed. Yet, the more important finding may be the fact that, with or without data adjustments, emerging-market stocks may be sporting a sale price that is nearly 2/3 of the value commanded six years ago. Slowdown fears and outright economic contraction concerns have adversely impacted funds like iShares MSCI Brazil Capped ( EWZ), Market Vectors Russia ETF ( RSX), WisdomTree India Earnings ( EPI) and SPDR S&P China ( GXC) for several years. Moreover, central bank policies in the developing world have been less stimulative than the policies of developed countries, causing many to back away altogether. In truth, those that have invested in up-n-coming regions over the last 12 months have more often felt the stabbing pain of the proverbial falling knife, not the the sweet sensation of biting into a Brazilian papaya.
Nevertheless, some emerging-market assets may finally be turning the corner. For example, iShares MSCI Malaysia ( EWM) has produced a respectable 15% year-over-year. Its current price is holding above a 50-day and 200-day trendline. In addition, the 50-day intermediate term moving average has stayed above the longer-term 200-day; technical analysts see the development as noteworthy because a bearish "cross-under" has been avoided. What if valuation is not the key to success with your emerging-market pick? For example, Poland has cut rates at a remarkably fast clip, sending its overnight bank lending rates to a record low (2.5%). In an investing world where the most monetary stimulus means the best investment, Poland has been a brighter spot than the neighboring euro-zone. One can look at either iShares MSCI Poland ( EPOL) or Market Vectors Poland ( PLND).